nodes	percent_of_prediction	percent_of_DWPC	metapath
Tizanidine—CYP1A2—urine—polycystic ovary syndrome	0.0215	0.121	CbGeAlD
Tizanidine—NISCH—adrenal cortex—polycystic ovary syndrome	0.0143	0.0809	CbGeAlD
Tizanidine—Apraclonidine—ADRA1A—polycystic ovary syndrome	0.0132	0.296	CrCbGaD
Tizanidine—NISCH—uterus—polycystic ovary syndrome	0.0118	0.0666	CbGeAlD
Tizanidine—NISCH—pituitary gland—polycystic ovary syndrome	0.0116	0.0654	CbGeAlD
Tizanidine—NISCH—adipose tissue—polycystic ovary syndrome	0.0115	0.0651	CbGeAlD
Tizanidine—Clonidine—ADRA1D—polycystic ovary syndrome	0.0115	0.259	CrCbGaD
Tizanidine—NISCH—adrenal gland—polycystic ovary syndrome	0.0104	0.0584	CbGeAlD
Tizanidine—Clonidine—ADRA1B—polycystic ovary syndrome	0.00985	0.221	CrCbGaD
Tizanidine—NISCH—female gonad—polycystic ovary syndrome	0.00966	0.0545	CbGeAlD
Tizanidine—NISCH—vagina—polycystic ovary syndrome	0.0096	0.0541	CbGeAlD
Tizanidine—Clonidine—ADRA1A—polycystic ovary syndrome	0.00663	0.149	CrCbGaD
Tizanidine—ADRA2C—adrenal cortex—polycystic ovary syndrome	0.00655	0.037	CbGeAlD
Tizanidine—ADRA2C—endometrium—polycystic ovary syndrome	0.00585	0.033	CbGeAlD
Tizanidine—ADRA2C—uterus—polycystic ovary syndrome	0.00539	0.0304	CbGeAlD
Tizanidine—ADRA2C—pituitary gland—polycystic ovary syndrome	0.0053	0.0299	CbGeAlD
Tizanidine—ADRA2C—adipose tissue—polycystic ovary syndrome	0.00527	0.0297	CbGeAlD
Tizanidine—ADRA2C—adrenal gland—polycystic ovary syndrome	0.00473	0.0267	CbGeAlD
Tizanidine—ADRA2A—endometrium—polycystic ovary syndrome	0.00467	0.0263	CbGeAlD
Tizanidine—Neuropathy—Metformin—polycystic ovary syndrome	0.00458	0.0422	CcSEcCtD
Tizanidine—ADRA2C—female gonad—polycystic ovary syndrome	0.00441	0.0249	CbGeAlD
Tizanidine—ADRA2C—vagina—polycystic ovary syndrome	0.00438	0.0247	CbGeAlD
Tizanidine—ADRA2A—uterus—polycystic ovary syndrome	0.0043	0.0243	CbGeAlD
Tizanidine—ADRA2A—pituitary gland—polycystic ovary syndrome	0.00423	0.0238	CbGeAlD
Tizanidine—ADRA2A—adipose tissue—polycystic ovary syndrome	0.00421	0.0237	CbGeAlD
Tizanidine—Ear pain—Metformin—polycystic ovary syndrome	0.00415	0.0382	CcSEcCtD
Tizanidine—ADRA2A—adrenal gland—polycystic ovary syndrome	0.00378	0.0213	CbGeAlD
Tizanidine—CYP1A2—endocrine gland—polycystic ovary syndrome	0.00356	0.0201	CbGeAlD
Tizanidine—ADRA2A—female gonad—polycystic ovary syndrome	0.00352	0.0199	CbGeAlD
Tizanidine—ADRA2A—vagina—polycystic ovary syndrome	0.0035	0.0197	CbGeAlD
Tizanidine—Migraine—Metformin—polycystic ovary syndrome	0.00349	0.0321	CcSEcCtD
Tizanidine—Clonidine—CYP1A1—polycystic ovary syndrome	0.00338	0.0757	CrCbGaD
Tizanidine—ADRA2A—endocrine gland—polycystic ovary syndrome	0.00327	0.0185	CbGeAlD
Tizanidine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00327	0.0301	CcSEcCtD
Tizanidine—Influenza—Metformin—polycystic ovary syndrome	0.00306	0.0282	CcSEcCtD
Tizanidine—Angina pectoris—Metformin—polycystic ovary syndrome	0.00298	0.0274	CcSEcCtD
Tizanidine—Drowsiness—Metformin—polycystic ovary syndrome	0.00273	0.0251	CcSEcCtD
Tizanidine—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00267	0.0246	CcSEcCtD
Tizanidine—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00258	0.0238	CcSEcCtD
Tizanidine—Bradycardia—Metformin—polycystic ovary syndrome	0.00249	0.023	CcSEcCtD
Tizanidine—Rhinitis—Metformin—polycystic ovary syndrome	0.00246	0.0226	CcSEcCtD
Tizanidine—Hepatitis—Metformin—polycystic ovary syndrome	0.00245	0.0225	CcSEcCtD
Tizanidine—Connective tissue disorder—Metformin—polycystic ovary syndrome	0.00241	0.0222	CcSEcCtD
Tizanidine—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00227	0.0209	CcSEcCtD
Tizanidine—Angiopathy—Metformin—polycystic ovary syndrome	0.00222	0.0205	CcSEcCtD
Tizanidine—Immune system disorder—Metformin—polycystic ovary syndrome	0.00221	0.0204	CcSEcCtD
Tizanidine—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00221	0.0203	CcSEcCtD
Tizanidine—Flatulence—Metformin—polycystic ovary syndrome	0.0021	0.0193	CcSEcCtD
Tizanidine—Muscle spasms—Metformin—polycystic ovary syndrome	0.00205	0.0189	CcSEcCtD
Tizanidine—Vision blurred—Metformin—polycystic ovary syndrome	0.00201	0.0185	CcSEcCtD
Tizanidine—Tremor—Metformin—polycystic ovary syndrome	0.002	0.0184	CcSEcCtD
Tizanidine—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00198	0.0182	CcSEcCtD
Tizanidine—Malaise—Metformin—polycystic ovary syndrome	0.00192	0.0177	CcSEcCtD
Tizanidine—Syncope—Metformin—polycystic ovary syndrome	0.00191	0.0176	CcSEcCtD
Tizanidine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00187	0.0173	CcSEcCtD
Tizanidine—Hypertension—Metformin—polycystic ovary syndrome	0.00184	0.0169	CcSEcCtD
Tizanidine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.0018	0.0166	CcSEcCtD
Tizanidine—Discomfort—Metformin—polycystic ovary syndrome	0.00179	0.0165	CcSEcCtD
Tizanidine—Oedema—Metformin—polycystic ovary syndrome	0.00174	0.016	CcSEcCtD
Tizanidine—Infection—Metformin—polycystic ovary syndrome	0.00173	0.0159	CcSEcCtD
Tizanidine—Shock—Metformin—polycystic ovary syndrome	0.00171	0.0158	CcSEcCtD
Tizanidine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00171	0.0157	CcSEcCtD
Tizanidine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.0017	0.0157	CcSEcCtD
Tizanidine—Skin disorder—Metformin—polycystic ovary syndrome	0.00169	0.0156	CcSEcCtD
Tizanidine—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00168	0.0155	CcSEcCtD
Tizanidine—Hypotension—Metformin—polycystic ovary syndrome	0.00163	0.015	CcSEcCtD
Tizanidine—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00159	0.0146	CcSEcCtD
Tizanidine—Paraesthesia—Metformin—polycystic ovary syndrome	0.00156	0.0144	CcSEcCtD
Tizanidine—Dyspnoea—Metformin—polycystic ovary syndrome	0.00155	0.0143	CcSEcCtD
Tizanidine—Somnolence—Metformin—polycystic ovary syndrome	0.00155	0.0142	CcSEcCtD
Tizanidine—Dyspepsia—Metformin—polycystic ovary syndrome	0.00153	0.0141	CcSEcCtD
Tizanidine—Fatigue—Metformin—polycystic ovary syndrome	0.0015	0.0138	CcSEcCtD
Tizanidine—Constipation—Metformin—polycystic ovary syndrome	0.00149	0.0137	CcSEcCtD
Tizanidine—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00143	0.0132	CcSEcCtD
Tizanidine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00142	0.0131	CcSEcCtD
Tizanidine—Urticaria—Metformin—polycystic ovary syndrome	0.00138	0.0127	CcSEcCtD
Tizanidine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00138	0.0127	CcSEcCtD
Tizanidine—Asthenia—Metformin—polycystic ovary syndrome	0.00125	0.0115	CcSEcCtD
Tizanidine—Pruritus—Metformin—polycystic ovary syndrome	0.00123	0.0113	CcSEcCtD
Tizanidine—Diarrhoea—Metformin—polycystic ovary syndrome	0.00119	0.011	CcSEcCtD
Tizanidine—Dizziness—Metformin—polycystic ovary syndrome	0.00115	0.0106	CcSEcCtD
Tizanidine—Vomiting—Metformin—polycystic ovary syndrome	0.00111	0.0102	CcSEcCtD
Tizanidine—Rash—Metformin—polycystic ovary syndrome	0.0011	0.0101	CcSEcCtD
Tizanidine—Dermatitis—Metformin—polycystic ovary syndrome	0.0011	0.0101	CcSEcCtD
Tizanidine—Nausea—Metformin—polycystic ovary syndrome	0.00103	0.00952	CcSEcCtD
Tizanidine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000226	0.000337	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000225	0.000336	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—LHB—polycystic ovary syndrome	0.000225	0.000336	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000224	0.000335	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000221	0.00033	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—HSD3B2—polycystic ovary syndrome	0.00022	0.000328	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000218	0.000325	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000217	0.000325	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LPCAT2—polycystic ovary syndrome	0.000217	0.000324	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SUOX—polycystic ovary syndrome	0.000217	0.000324	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000216	0.000323	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000214	0.00032	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKR1C1—polycystic ovary syndrome	0.000213	0.000318	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000212	0.000316	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000211	0.000316	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000211	0.000316	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.00021	0.000314	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HMMR—polycystic ovary syndrome	0.00021	0.000313	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000206	0.000308	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FST—polycystic ovary syndrome	0.000206	0.000308	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000205	0.000306	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000204	0.000304	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000203	0.000303	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—ISYNA1—polycystic ovary syndrome	0.000202	0.000301	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LHB—polycystic ovary syndrome	0.000201	0.0003	CbGpPWpGaD
Tizanidine—CYP1A2—Biological oxidations—POMC—polycystic ovary syndrome	0.000201	0.0003	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HSD3B1—polycystic ovary syndrome	0.0002	0.000299	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000198	0.000295	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000197	0.000294	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000197	0.000294	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—SULT2A1—polycystic ovary syndrome	0.000196	0.000292	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—IGF1—polycystic ovary syndrome	0.000195	0.000291	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—AKT2—polycystic ovary syndrome	0.000195	0.000291	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000193	0.000288	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FST—polycystic ovary syndrome	0.000192	0.000288	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000191	0.000286	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.00019	0.000284	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—RRM2—polycystic ovary syndrome	0.00019	0.000283	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SCT—polycystic ovary syndrome	0.000188	0.000282	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LHB—polycystic ovary syndrome	0.000188	0.000281	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000188	0.000281	CbGpPWpGaD
Tizanidine—ADRA2A—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000187	0.00028	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000186	0.000278	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000185	0.000276	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000184	0.000275	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000184	0.000274	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—YAP1—polycystic ovary syndrome	0.000183	0.000273	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—LHB—polycystic ovary syndrome	0.000182	0.000273	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—IGF1—polycystic ovary syndrome	0.000182	0.000272	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—AKT2—polycystic ovary syndrome	0.000182	0.000271	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00018	0.000269	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—HSD3B2—polycystic ovary syndrome	0.000178	0.000266	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000178	0.000266	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000177	0.000265	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000177	0.000264	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SCT—polycystic ovary syndrome	0.000176	0.000263	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NAMPT—polycystic ovary syndrome	0.000176	0.000262	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000175	0.000262	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000175	0.000262	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000175	0.000261	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000174	0.00026	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP11A1—polycystic ovary syndrome	0.000173	0.000259	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKR1C1—polycystic ovary syndrome	0.000173	0.000258	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—SERPINE1—polycystic ovary syndrome	0.000173	0.000258	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000173	0.000258	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000172	0.000257	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKR1C2—polycystic ovary syndrome	0.000171	0.000256	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TEAD2—polycystic ovary syndrome	0.000171	0.000256	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000171	0.000255	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000168	0.000251	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000165	0.000247	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.000165	0.000246	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000165	0.000246	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—AKR1C3—polycystic ovary syndrome	0.000164	0.000245	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000164	0.000244	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000164	0.000244	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000162	0.000242	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000161	0.000241	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP17A1—polycystic ovary syndrome	0.000161	0.000241	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000161	0.000241	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00016	0.00024	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—SULT2A1—polycystic ovary syndrome	0.000159	0.000237	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FST—polycystic ovary syndrome	0.000156	0.000234	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000155	0.000232	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000154	0.000231	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—INSR—polycystic ovary syndrome	0.000154	0.00023	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—RRM2—polycystic ovary syndrome	0.000154	0.00023	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000153	0.000228	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LHB—polycystic ovary syndrome	0.000153	0.000228	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000151	0.000225	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000149	0.000223	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—YAP1—polycystic ovary syndrome	0.000148	0.000222	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—IGF1—polycystic ovary syndrome	0.000148	0.000221	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—AKT2—polycystic ovary syndrome	0.000148	0.000221	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000147	0.000219	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000144	0.000216	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000144	0.000216	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—INSR—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	0.000144	0.000215	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SCT—polycystic ovary syndrome	0.000143	0.000214	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PGR—polycystic ovary syndrome	0.000143	0.000213	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NAMPT—polycystic ovary syndrome	0.000143	0.000213	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000141	0.000211	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP11A1—polycystic ovary syndrome	0.000141	0.00021	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—SERPINE1—polycystic ovary syndrome	0.00014	0.00021	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—TH—polycystic ovary syndrome	0.000139	0.000208	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000137	0.000205	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000136	0.000204	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	0.000136	0.000203	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—SLC2A4—polycystic ovary syndrome	0.000136	0.000203	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000135	0.000201	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000134	0.0002	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PGR—polycystic ovary syndrome	0.000133	0.000199	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—AKR1C3—polycystic ovary syndrome	0.000133	0.000199	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000133	0.000199	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000133	0.000198	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000133	0.000198	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP17A1—polycystic ovary syndrome	0.000131	0.000196	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000131	0.000196	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	0.00013	0.000194	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000128	0.000192	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000128	0.000191	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP19A1—polycystic ovary syndrome	0.000128	0.000191	CbGpPWpGaD
Tizanidine—ADRA2B—Hemostasis—VEGFA—polycystic ovary syndrome	0.000127	0.00019	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000127	0.000189	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000124	0.000185	CbGpPWpGaD
Tizanidine—ADRA2B—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000123	0.000184	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000122	0.000183	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000119	0.000179	CbGpPWpGaD
Tizanidine—ADRA2C—Hemostasis—VEGFA—polycystic ovary syndrome	0.000119	0.000177	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000118	0.000177	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INSR—polycystic ovary syndrome	0.000117	0.000175	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000117	0.000175	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000116	0.000174	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—PRL—polycystic ovary syndrome	0.000116	0.000173	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	0.000116	0.000173	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000115	0.000172	CbGpPWpGaD
Tizanidine—ADRA2C—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000115	0.000172	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—GNAS—polycystic ovary syndrome	0.000114	0.00017	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—TH—polycystic ovary syndrome	0.000113	0.000169	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000112	0.000167	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000111	0.000166	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	0.00011	0.000165	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—SLC2A4—polycystic ovary syndrome	0.00011	0.000165	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00011	0.000164	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000109	0.000164	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000109	0.000163	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000109	0.000162	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—NCOR1—polycystic ovary syndrome	0.000108	0.000162	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PGR—polycystic ovary syndrome	0.000108	0.000162	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—PRL—polycystic ovary syndrome	0.000108	0.000162	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000104	0.000156	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP19A1—polycystic ovary syndrome	0.000104	0.000155	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000104	0.000155	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—CYP1A1—polycystic ovary syndrome	0.000103	0.000154	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000103	0.000153	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000102	0.000152	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000101	0.00015	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000101	0.00015	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	0.000101	0.00015	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	9.85e-05	0.000147	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.71e-05	0.000145	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—POMC—polycystic ovary syndrome	9.71e-05	0.000145	CbGpPWpGaD
Tizanidine—ADRA2A—Hemostasis—VEGFA—polycystic ovary syndrome	9.65e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ATF1—polycystic ovary syndrome	9.61e-05	0.000144	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—MTHFR—polycystic ovary syndrome	9.58e-05	0.000143	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	9.54e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—NRG1—polycystic ovary syndrome	9.53e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—GNAS—polycystic ovary syndrome	9.52e-05	0.000142	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—TCF7L2—polycystic ovary syndrome	9.37e-05	0.00014	CbGpPWpGaD
Tizanidine—ADRA2A—GPCR downstream signaling—AKT2—polycystic ovary syndrome	9.33e-05	0.000139	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—GNAS—polycystic ovary syndrome	9.25e-05	0.000138	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.07e-05	0.000135	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—NRG1—polycystic ovary syndrome	8.9e-05	0.000133	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NGFR—polycystic ovary syndrome	8.87e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—POMC—polycystic ovary syndrome	8.81e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—NCOR1—polycystic ovary syndrome	8.81e-05	0.000132	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—PRL—polycystic ovary syndrome	8.79e-05	0.000131	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	8.78e-05	0.000131	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.5e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—AKT2—polycystic ovary syndrome	8.47e-05	0.000127	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—CYP1A1—polycystic ovary syndrome	8.35e-05	0.000125	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—ADRB2—polycystic ovary syndrome	8.34e-05	0.000125	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.19e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS2—polycystic ovary syndrome	8.16e-05	0.000122	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—LEP—polycystic ovary syndrome	7.99e-05	0.000119	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	7.87e-05	0.000118	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	7.83e-05	0.000117	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—MTHFR—polycystic ovary syndrome	7.79e-05	0.000116	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	7.77e-05	0.000116	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—PPARG—polycystic ovary syndrome	7.77e-05	0.000116	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—GNAS—polycystic ovary syndrome	7.73e-05	0.000116	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	7.72e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—POMC—polycystic ovary syndrome	7.67e-05	0.000115	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS2—polycystic ovary syndrome	7.62e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2C—Metabolism—INS—polycystic ovary syndrome	7.62e-05	0.000114	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—LEP—polycystic ovary syndrome	7.46e-05	0.000111	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NCOR1—polycystic ovary syndrome	7.37e-05	0.00011	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.34e-05	0.00011	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—NRG1—polycystic ovary syndrome	7.23e-05	0.000108	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.23e-05	0.000108	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IRS1—polycystic ovary syndrome	7.13e-05	0.000106	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—POMC—polycystic ovary syndrome	6.86e-05	0.000103	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—INS—polycystic ovary syndrome	6.82e-05	0.000102	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IRS1—polycystic ovary syndrome	6.66e-05	9.94e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IGF1—polycystic ovary syndrome	6.6e-05	9.86e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—AKT2—polycystic ovary syndrome	6.6e-05	9.85e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—POMC—polycystic ovary syndrome	6.41e-05	9.58e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—INS—polycystic ovary syndrome	6.37e-05	9.52e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—PPARG—polycystic ovary syndrome	6.31e-05	9.43e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.27e-05	9.36e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.25e-05	9.34e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—POMC—polycystic ovary syndrome	6.23e-05	9.3e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS2—polycystic ovary syndrome	6.19e-05	9.25e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Metabolism—INS—polycystic ovary syndrome	6.19e-05	9.25e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IGF1—polycystic ovary syndrome	6.17e-05	9.21e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—AKT2—polycystic ovary syndrome	6.16e-05	9.2e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.08e-05	9.09e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—LEP—polycystic ovary syndrome	6.06e-05	9.05e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.85e-05	8.75e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	5.72e-05	8.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IRS1—polycystic ovary syndrome	5.41e-05	8.08e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—POMC—polycystic ovary syndrome	5.21e-05	7.78e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—INS—polycystic ovary syndrome	5.18e-05	7.73e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.1e-05	7.63e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling by GPCR—IL6—polycystic ovary syndrome	5.05e-05	7.54e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IGF1—polycystic ovary syndrome	5.01e-05	7.48e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—AKT2—polycystic ovary syndrome	5e-05	7.48e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	4.86e-05	7.26e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—SERPINE1—polycystic ovary syndrome	4.76e-05	7.1e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling by GPCR—IL6—polycystic ovary syndrome	4.71e-05	7.04e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.61e-05	6.89e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.31e-05	6.44e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.3e-05	6.42e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.03e-05	6.02e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling by GPCR—IL6—polycystic ovary syndrome	3.83e-05	5.72e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.48e-05	5.21e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.44e-05	5.13e-05	CbGpPWpGaD
Tizanidine—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.42e-05	5.11e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.27e-05	4.89e-05	CbGpPWpGaD
Tizanidine—ADRA2B—Signaling Pathways—IL6—polycystic ovary syndrome	2.98e-05	4.45e-05	CbGpPWpGaD
Tizanidine—ADRA2C—Signaling Pathways—IL6—polycystic ovary syndrome	2.79e-05	4.16e-05	CbGpPWpGaD
Tizanidine—ADRA2A—Signaling Pathways—IL6—polycystic ovary syndrome	2.26e-05	3.38e-05	CbGpPWpGaD
